These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 3485701)
1. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. Vyas I; Heikkila RE; Nicklas WJ J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701 [TBL] [Abstract][Full Text] [Related]
2. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), cyperquat (MPP+) and paraquat on isolated mitochondria from rat striatum, cortex and liver. Thakar JH; Hassan MN Life Sci; 1988; 43(2):143-9. PubMed ID: 3260653 [TBL] [Abstract][Full Text] [Related]
3. MPTP, MPP+ and mitochondrial function. Nicklas WJ; Youngster SK; Kindt MV; Heikkila RE Life Sci; 1987 Feb; 40(8):721-9. PubMed ID: 3100899 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Nicklas WJ; Vyas I; Heikkila RE Life Sci; 1985 Jul; 36(26):2503-8. PubMed ID: 2861548 [TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver. Thakar JH; Hassan MN; Grimes JD Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):355-62. PubMed ID: 3260387 [TBL] [Abstract][Full Text] [Related]
7. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity. Kinemuchi H; Arai Y; Toyoshima Y Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524 [TBL] [Abstract][Full Text] [Related]
8. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae. Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651 [TBL] [Abstract][Full Text] [Related]
9. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite. Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810 [TBL] [Abstract][Full Text] [Related]
10. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Heikkila RE; Nicklas WJ; Vyas I; Duvoisin RC Neurosci Lett; 1985 Dec; 62(3):389-94. PubMed ID: 3912685 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion. Hirata Y; Nagatsu T Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190 [TBL] [Abstract][Full Text] [Related]
12. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Cosi C; Marien M Brain Res; 1998 Oct; 809(1):58-67. PubMed ID: 9795136 [TBL] [Abstract][Full Text] [Related]
13. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. Mizuno Y; Sone N; Saitoh T J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573 [TBL] [Abstract][Full Text] [Related]
14. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions. Sirinathsinghji DJ; Heavens RP; McBride CS Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784 [TBL] [Abstract][Full Text] [Related]
15. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its metabolite 1-methyl-4-phenylpyridine on acetylcholine synthesis in synaptosomes from rat forebrain. Cheeseman AJ; Clark JB J Neurochem; 1987 Apr; 48(4):1209-14. PubMed ID: 3102694 [TBL] [Abstract][Full Text] [Related]
16. MPTP causes a non-reversible depression of synaptic transmission in mouse neostriatal brain slice. Wilson JA; Wilson JS; Weight FF Brain Res; 1986 Mar; 368(2):357-60. PubMed ID: 3008929 [TBL] [Abstract][Full Text] [Related]
17. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals. Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070 [TBL] [Abstract][Full Text] [Related]
18. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates. RĂos C; Tapia R Neurosci Lett; 1987 Jun; 77(3):321-6. PubMed ID: 3497366 [TBL] [Abstract][Full Text] [Related]
19. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+. Nakamura S; Vincent SR Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052 [TBL] [Abstract][Full Text] [Related]
20. Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+. Ramsay RR; Salach JI; Singer TP Biochem Biophys Res Commun; 1986 Jan; 134(2):743-8. PubMed ID: 2868716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]